Serina Therapeutics, Inc. (SER) Gross margin 2017–2023
Serina Therapeutics, Inc. (SER) gross margin by fiscal year — reported gross profit divided by reported revenue.
3.2%FY2023 · since FY2017: 88.0% → 3.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 3.2% | -58.5 pp |
| FY2022 | 61.8% | -25.0 pp |
| FY2021 | 86.8% | -6.0 pp |
| FY2020 | 92.8% | +6.9 pp |
| FY2019 | 85.9% | +12.0 pp |
| FY2018 | 73.9% | -14.1 pp |
| FY2017 | 88.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice